Table 3.
Best response to treatment with AZT/VGC in 14 patients with symptomatic KSHV-MCD
| Response category | Best response | No. (%) |
|---|---|---|
| Clinical response | Complete response | 7 (50) |
| Symptom-free disease | 3 (21) | |
| Partial response | 2 (14) | |
| Major clinical response | 12 (86) | |
| Stable disease | 2 (14) | |
| Biochemical response | Complete response | 3 (21) |
| Partial response | 4 (29) | |
| Major biochemical response | 7 (50) | |
| Stable disease | 6 (43) | |
| Progressive disease | 1 (7) | |
| Radiographic response* | Complete response | 4 (29) |
| Complete response, unconfirmed | 1 (7) | |
| Major radiographic response | 5 (36) | |
| Stable disease | 8 (67) | |
| Overall response | Complete response | 3 (21) |
| Partial response | 1 (7) | |
| Stable disease | 9 (64) | |
| Progressive disease | 1 (7) |
Major clinical response = complete response + symptom-free disease + partial response; major biochemical response = complete response + partial response; and major radiographic response = complete response + complete response unconfirmed + partial response.
*
One patient was not evaluable radiographically.